A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers
Clinical trial NCT06518122 · COMPLETED
Trial details
- NCT number
- NCT06518122
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-01-03
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.